ANTIRESDEV is a medium-scale, focussed and objective-driven collaborative project.

Its aims are to study the effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites.

Further information about the project and its objectives can be found on a summary leaflet.

• The lifespan of the project is 42 months.
• The start date of the project was 01 November 2009.
• ANTIRESDEV consists of 10 partners throughout Europe.
• It is a project funded by the European Commission - Seventh Framework Programme, Health Theme.
• ANTIRESDEV was awarded € 5,368,088.00.